The global AI in oncology market, valued at US$1.92 billion in 2023, is forecasted to grow at a robust CAGR of 29.4%, reaching US$2.45 billion in 2024 and an impressive US$11.52 billion by 2030. The ...
The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...
Dr. Maxwell Lloyd discusses the long-term management of patients with HR-positive, HER2-negative breast cancer who have received Orserdu treatment.
A drug from AstraZeneca and Daiichi Sankyo won authorization for a form of breast cancer, the first U.S. approval for the ...
On Jan. 7, 2025, Nebraska Gov. Jim Pillen proclaimed the month of January as Cervical Cancer Prevention Month. While cervical cancer continues to impact women across Nebraska, ...
Today, the National Comprehensive Cancer Network (NCCN)-an alliance of leading cancer centers-published a new resource to inform people about the latest recommendations around hereditary and familial ...
The gut microbiome, or the community of microorganisms residing in the gastrointestinal tract, has emerged as an important ...
Estimated numbers of new cancer cases and deaths in 2025 by cancer site and US state Current cancer incidence, mortality, and ...
No scientific studies have established a causal relationship between the Pfizer vaccine and conditions that cause the ...
Breast Cancer Diagnostic And Drug Technologies Market Breast cancer is the most common cancer among women worldwide, with an estimated 2.3 ...
An American Society of Radiation Oncology survey has shined a spotlight on the impact prior authorization has on providers and patients.Nearly one-third of the more than 750 radiation oncologists who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback